XML 22 R4.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Operating expenses:        
Research and development $ 40,148 $ 18,857 $ 100,807 $ 29,411
In process research and development   8,261 2,000 49,659
General and administrative 9,838 22,906 27,544 30,116
Total operating expenses 49,986 50,024 130,351 109,186
Loss from operations (49,986) (50,024) (130,351) (109,186)
Other income, net 1,486 622 4,742 1,011
Net loss (48,500) (49,402) (125,609) (108,175)
Other comprehensive income:        
Unrealized gain (loss) on marketable securities, net of tax (168) 232 389 235
Other comprehensive income (loss) (168) 232 389 235
Comprehensive loss $ (48,668) $ (49,170) $ (125,220) $ (107,940)
Net loss per share, basic and diluted $ (0.80) $ (7.69) $ (2.39) $ (17.64)
Weighted average common shares outstanding, basic and diluted 60,755,872 6,423,397 52,535,569 6,133,911